Abstract
Interferon-γ release assay (IGRA) is an in vitro immunological technique for Mycobacterium tuberculosis diagnosis, which is recommended by the World Health Organization. As one of the auxiliary diagnosis methods for active tuberculosis in diagnostic criteria of China, the method and technique have been developed in recent years, and a wealth of clinical applied experience has been accumulated in the clinical application in China. Based on the "Opinions of applications of IGRA in China (2014 edition)" issued by Chinese Society for Tuberculosis, Chinese Medical Association, it was revised and improved according to the latest developments and clinical experience, and the expert opinions were presented in six parts: principles and technical advances, quality control, application of latent tuberculosis infection diagnosis, auxiliary diagnosis of active tuberculosis, application in special populations, and the influence of common drugs on IGRA results, with a view to providing guidance for the clinical application of IGRA in China.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.